Four foreign firms producing OTC drugs susceptible to diethylene glycol and ethylene glycol substitution failed to reply to US regulators’ recent requests for information on their good manufacturing practices compliance while another six were warned about GMP violations concerning testing for the substances.
Foreign OTC Firms Fail US FDA Review Of Records For Diethylene Glycol Testing, Or Fail To Reply
Two firms in India, two in South Korea manufacturing toothpastes and hand sanitizers available in US didn’t respond to FDA’s repeated records requests. Six others in those two countries and Canada and Turkey making sanitizers and toothpastes, including products for children, as well as sunscreens were warned about GMP failures after providing records at agency’s request.